LISATA THERAPEUTICS, INC. Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions
LISATA THERAPEUTICS, INC. (LSTA) reported Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions of -$2.90 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-10-30.
Discontinued › Notes
us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions · last filed 2014-10-30
- LISATA THERAPEUTICS, INC. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2014-09-30 was -$2.90M.
| Period end | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 3 month |
|---|---|
| 2014-09-30 | -$2.90M 10-Q · filed 2014-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |